Exploring Human-Relevant Models of Neuroinflammation: Joint SfN Poster with Merakris Therapeutics
November 10, 2025 – Research Triangle Park, NC We’re excited to share that Xona Microfluidics will be presenting a joint poster with our collaborators at Merakris Therapeutics at the upcoming Society for Neuroscience (SfN) Annual Meeting in San Diego, California, on...
Xona Microfluidics and Healx Limited to Present Collaborative Research at the 2025 Society for Neuroscience Annual Meeting
November 6, 2025 — Research Triangle Park, NC & Cambridge, UK — Xona Microfluidics, Inc. (“Xona”) and Healx Limited (“Healx”) are pleased to announce a joint presentation at the Society for Neuroscience (SfN) Annual Meeting on Saturday afternoon, November 15,...
Activation of human iPSC-derived microglia compartmentalized in XonaChips®
Neuroinflammation plays an important role in the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease (AD) and ALS. Microglial activation, indicative of neuroinflammation, is present in patients with AD. One of Xona’s goals is to model...
Growing hiPSC motor neurons in the X4 XonaChip®
Our newest X4 chip (catalog # XC-SF150-X4) uses fewer neurons per culture unit, thereby increasing sample size given a finite number of neurons. Cell loading is also optimized and the chip is a great improvement for automated imaging studies. Recently we cultured...